Decoding the Anticancer Potential of Natural N-Heterocycles: Molecular Frameworks, Bioactivity, and Mechanistic...

Area of Science:

• Pharmacology
• Oncology
• Materials Science

Background:

• Cancer remains a leading global cause of death and disease.
• Developing potent, less toxic anticancer drugs is a critical research area.
• N-heterocyclic moieties are a class of compounds with potential anticancer properties.

Purpose of the Study:

• To review recent research (2020-2025) on natural N-heterocyclic compounds as anticancer agents.
• To integrate mechanistic insights, nanotechnology delivery, and translational progress.
• To evaluate the potential of combining natural N-heterocycles with nanotechnology for cancer therapy.

Main Methods:

• Literature search of PubMed, Science Direct, Embase, and Google Scholar.
• Keywords included 'Natural N-heterocyclic products' and 'anticancer activity'.
• Focus on research published between 2020 and 2025.

Main Results:

• Natural N-heterocyclic compounds demonstrate significant anticancer potential.
• Nanotechnology offers novel delivery systems for these agents.
• Integration of natural N-heterocycles and nanotechnology shows promise for reduced toxicity.

Conclusions:

• Combining natural N-heterocyclic compounds with nanotechnology is a promising strategy for developing next-generation anticancer drugs.
• This approach has the potential to significantly reduce drug toxicity.
• Further research is essential to fully realize the therapeutic potential of this combination therapy.